BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31059181)

  • 1. Carbon monoxide releasing molecule enhances coagulation and decreases fibrinolysis in canine plasma exposed to Crotalus viridis venom in vitro and in vivo.
    Johnson TE; Wells RJ; Bell A; Nielsen VG; Olver CS
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):328-336. PubMed ID: 31059181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crotalus atrox Venom Exposed to Carbon Monoxide Has Decreased Fibrinogenolytic Activity In Vivo in Rabbits.
    Nielsen VG
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):82-86. PubMed ID: 28691277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
    Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
    Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.
    Nielsen VG
    J Thromb Thrombolysis; 2016 Jul; 42(1):33-7. PubMed ID: 26407681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of canine whole blood with the addition of Crotalus atrox (Western Diamondback Rattlesnake) venom and antivenom using thromboelastography.
    Altemus Bailey SR; Lyon SD; Gilliam LL
    J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):616-622. PubMed ID: 35712887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Iron and Carbon Monoxide on Fibrinogenase-like Degradation of Plasmatic Coagulation by Venoms of Six Agkistrodon Species.
    Nielsen VG; Redford DT; Boyle PK
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):390-5. PubMed ID: 26467642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
    Nielsen VG; George SJ
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Rabbit as an In Vitro and In Vivo Model to Assess the Effects of Fibrinogenolytic Activity of Snake Venom on Coagulation.
    Nielsen VG; Sánchez EE; Redford DT
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):157-164. PubMed ID: 28696521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron and carbon monoxide prevent degradation of plasmatic coagulation by thrombin-like activity in rattlesnake venom.
    Nielsen VG
    Hum Exp Toxicol; 2016 Oct; 35(10):1116-22. PubMed ID: 26666988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and carbon monoxide attenuate degradation of plasmatic coagulation by Crotalus atrox venom.
    Nielsen VG; Boyer LV
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):506-10. PubMed ID: 26575491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of four Crotalus species.
    Nielsen VG; Redford DT; Boyle PK
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):34-39. PubMed ID: 26845427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastography with Platelet Studies (TEG® with PlateletMapping®) After Rattlesnake Envenomation in the Southwestern United States Demonstrates Inhibition of ADP-Induced Platelet Activation As Well As Clot Lysis.
    Kang AM; Fisher ES
    J Med Toxicol; 2020 Jan; 16(1):24-32. PubMed ID: 31407209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.